Item 2. Properties
Item 2. Properties.
Below is a summary of our leased properties as of December 31, 2020:
We lease approximately 29,000 square feet of combined laboratory and office space in Pittsburgh, Pennsylvania that we use for our research, development and manufacturing efforts. This lease expires in February 2027.
On December 26, 2019, we entered into a lease agreement for our second commercial gene therapy facility in the Pittsburgh, Pennsylvania area. The 150,000 square foot facility is under construction and is expected to be completed and validated in 2022. The lease commenced on February 1, 2021 when the Landlord delivered the space as substantially complete and made the space available for access by the Company. The lease has an initial term that expires on October 31, 2035 .
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.